Skip to main content

Month: May 2021

Sono-Tek Announces Sales of $14.8M for Fiscal Year 2021, Strong Yearend Backlog and Sales Guidance for Fiscal Year 2022

Backlog Increased 9.5% Year-over-Year MILTON, NY, May 28, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – Sono-Tek Corporation (OTCQX: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today reported financial results for its fourth quarter and fiscal year 2021, ended February 28, 2021 (“fiscal 2021”). Fiscal 2021 HighlightsBacklog on February 28, 2021 was up 9.5% compared to the backlog on February 29, 2020, a result of our ongoing strategy for product line expansion with further customization and automation, which delivers increased value to our customers, and a higher average selling price to Sono-Tek. During the unprecedented year of the COVID-19 pandemic, net sales for fiscal 2021 dipped only slightly to $14,833,000, down 3%, compared with $15,355,000 for fiscal 2020. This was achieved despite numerous...

Continue reading

Changes in investor calendar

AS Pro Kapital Grupp has previously informed about publishing 2020 audited results as soon as possible, but not later than on 28 May 2021. The Company cannot present audited report today. The new deadline of 11 June 2021 is agreed with the auditors. The report will be published as soon as possible.   Angelika AnnusCFOPhone: +372 614 4920e-mail: prokapital@prokapital.ee

Continue reading

Changes in investor calendar

AS Pro Kapital Grupp has previously informed about publishing 2020 audited results as soon as possible, but not later than on 28 May 2021. The Company cannot present audited report today. The new deadline of 11 June 2021 is agreed with the auditors. The report will be published as soon as possible.   Angelika AnnusCFOPhone: +372 614 4920e-mail: prokapital@prokapital.ee

Continue reading

Red Moon Closes $3.25 Million Financing

ST. JOHN’S, Newfoundland and Labrador, May 28, 2021 (GLOBE NEWSWIRE) — Red Moon Resources Inc. (the “Company” or “Red Moon” – TSXV: RMK) announces that it has closed a non-brokered private placement financing to raise total gross proceeds of $3.25 million. Patrick Laracy, Red Moon CEO, stated: “We welcome new strategic investors with this financing which builds on our already strong financial position. We’re extremely well positioned to execute on multiple fronts and further build shareholder value.” Under the terms of the offering, the Company placed 3,461,538 units at $0.65 per unit. Each unit consisted of one common share and one-half of a common share purchase warrant, with each whole warrant exercisable at a price of $0.90 per share for a period of two years following the close of the offering (subject to an acceleration...

Continue reading

Surgery Partners, Inc. and UCI Health Announce New Strategic Partnership

ORANGE, Calif., May 28, 2021 (GLOBE NEWSWIRE) — Surgery Partners, Inc. (NASDAQ:SGRY) and UCI Health have announced a new strategic partnership that marks an expansion of community access to outpatient surgical facilities for nearly 4 million residents throughout Orange County, western Riverside County and southern California. “We are excited about our joint venture with UCI Health, a renowned academic health system, and the opportunity it provides to further deliver on our mission to enhance patient quality of life through partnership,” said Eric Evans, Surgery Partners CEO. “As a leading, independent operator of short-stay surgical facilities, we look forward to partnering with UCI Health and our collective medical staffs to provide our patients a cost-effective solution for ambulatory procedures with the same high-quality care...

Continue reading

A First In France In The Crypto-Currency Sector: Euronext Paris Welcomes ETPs On Bitcoin And Ethereum From Swiss Pioneered Led Crypto Issuer 21Shares

A major step for the pan-European market operator and French investorsParis | Zurich, 28 Mai 2021 – 21Shares, the world’s most expansive issuer of cryptocurrency ETPs, is admitting to listing three of its ETPs namely on Bitcoin and Ethereum and the short Bitcoin on the regulated market of Euronext Paris on Tuesday, June 1st. 21Shares, a Swiss pioneering issuer of crypto ETPs, is assisting a first in France: the listing of liquid, secure, 100% collateralised financial products backed by the two “stars” of the new crypto-currency asset class, Bitcoin and Ethereum (respectively +39.53% and +265.37% since 1 January 2021). Since it’s world first product launch in November 2018 ( crypto basket HODL ETP), 21Shares has continued to build its unique expertise in the cryptoasset industry, and has made available to...

Continue reading

Central 1 reports 2021 first quarter financial results

VANCOUVER, British Columbia, May 28, 2021 (GLOBE NEWSWIRE) — Central 1 Credit Union (‘Central 1’ or ‘the organization’) reported a profit after tax of $24.7 million for the first quarter (Q1) ended March 31, 2021, compared to a loss of $37.3 million in the same period in 2020. In the first quarter of 2021, Central 1 reported strong results driven by the organization’s diversified business model, operational resilience managing the ongoing pandemic, and an improving economic environment. Central 1 maintained the confidence of the credit union system and supported members and clients with essential products and services. The organization continued strategic investments to enhance digital and payments capabilities to meet the changing demands of Canadians. “Central 1’s performance this quarter reflects our ability to adapt, our strong...

Continue reading

BridgeBio Pharma’s Affiliate QED Therapeutics and Partner Helsinn Group Announce FDA Approval of TRUSELTIQ™ (infigratinib) for Patients with Cholangiocarcinoma

Pivotal study demonstrated a clinically meaningful rate of tumor shrinkage (overall response rate) and duration of response in patients with previously-treated advanced cholangiocarcinoma (CCA) harboring an FGFR2 fusion or rearrangement BridgeBio, through its affiliate QED (“BridgeBio”), and Helsinn will co-commercialize TRUSELTIQ in the U.S. TRUSELTIQ is BridgeBio’s first FDA approved therapeutic in oncology and second approved therapeutic this year PALO ALTO, Calif. and LUGANO, Switzerland, May 28, 2021 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO), through its affiliate QED Therapeutics, Inc., and Helsinn Group today announced that the US Food and Drug Administration (FDA) has approved TRUSELTIQ™ (infigratinib) under the accelerated approval program for the treatment of patients with previously-treated locally advanced...

Continue reading

Correction of Press Release May 26, 2021 – RioCan Real Estate Investment Trust Announced Results of Voting at RioCan’s Annual Meeting

TORONTO, May 28, 2021 (GLOBE NEWSWIRE) — RioCan Real Estate Investment Trust (“RioCan” or the “Trust”) (TSX: REI.UN) today announced a correction to its previously issued press release on May 26, 2021 regarding the voting results at RioCan’s annual meeting. The correction relates to the total number of units represented by unitholders in person or by proxy at the Meeting. Correct information follows below. The total number of units represented by unitholders present in person or by proxy at the Meeting was 148,050,152, representing 46.66% of RioCan’s 317,262,819 outstanding units entitled to be voted. About RioCanRioCan is one of Canada’s largest real estate investment trusts. RioCan owns, manages and develops retail-focused, increasingly mixed-use properties located in prime, high-density transit-oriented areas where Canadians...

Continue reading

Marimaca Announces Results From Annual General Meeting

VANCOUVER, British Columbia, May 28, 2021 (GLOBE NEWSWIRE) — Marimaca Copper Corp. (“Marimaca Copper” or the “Company”) (TSX: MARI) is pleased to report that all of its incumbent directors were re-elected at its annual general meeting of shareholders, held virtually via webcast on Thursday, 27 May 2021 (the “Meeting”). Below are the detailed results of the votes cast by ballot (including votes cast by proxy) at the Meeting on the election of the Company’s directors.  VOTES FOR  VOTES WITHHELD  PERCENTAGE OF VOTES FORHayden Locke 52,138,274   25,116   99.95 %Alan J. Stephens 52,138,274   25,116   99.95 %Colin Kinley 51,838,588   324,802   99.38 %Michael Haworth 52,138,178   25,116   99.95 %Clive Newall 52,161,223   2,801   100 %Tim Petterson 52,161,223   2,801   100 %Please see the Company’s report of voting...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.